Home Tags ToxSYN™ technologies

Tag: toxSYN™ technologies

Acquisition of Synaffix Strengthens Lonza’s Bioconjugates Offering

In a statement earlier today, Lonza, a global manufacturing partner to the pharmaceutical, biotech and nutraceutical markets, confirmed that it has acquired Netherlands-based Synaffix, a biotechnology company focused on commercializing its clinical-stage technology platform for the development of antibody-drug conjugates (ADCs).

X